Profile
Full Name
Immunome, Inc.Ticker
NASDAQ: IMNMExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 2, 2020Indexes
Not includedWebsite
https://immunome.comEmployees
131Key Details
Price
$9.21(-4.86%)
Market cap
$801.68M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$9.04M(-35.50% YoY)
Annual EPS
-$5.00(+7.06% YoY)
Next earnings date
Nov 13, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Immunome, Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Sep 5, 25 Craig-Hallum
BuyAug 25, 25 Guggenheim
BuyAug 22, 25 Evercore ISI Group
OutperformAug 7, 25 JP Morgan
OverweightApr 2, 25 Lake Street
BuyMar 20, 25 Wedbush
OutperformMar 20, 25 Stephens & Co.
OverweightMar 20, 25 Guggenheim
BuyMar 11, 25 LifeSci Capital
OutperformNov 14, 24 Piper Sandler
OverweightInstitutional Ownership
- What is the ticker symbol for Immunome, Inc.?
- Does Immunome, Inc. pay dividends?
- What sector is Immunome, Inc. in?
- What industry is Immunome, Inc. in?
- What country is Immunome, Inc. based in?
- When did Immunome, Inc. go public?
- Is Immunome, Inc. in the S&P 500?
- Is Immunome, Inc. in the NASDAQ 100?
- Is Immunome, Inc. in the Dow Jones?
- When was Immunome, Inc.'s last earnings report?
- When does Immunome, Inc. report earnings?
What is the ticker symbol for Immunome, Inc.?
The ticker symbol for Immunome, Inc. is NASDAQ:IMNM
Does Immunome, Inc. pay dividends?
No, Immunome, Inc. does not pay dividends
What sector is Immunome, Inc. in?
Immunome, Inc. is in the Healthcare sector
What industry is Immunome, Inc. in?
Immunome, Inc. is in the Biotechnology industry
What country is Immunome, Inc. based in?
Immunome, Inc. is headquartered in United States
When did Immunome, Inc. go public?
Immunome, Inc.'s initial public offering (IPO) was on October 2, 2020
Is Immunome, Inc. in the S&P 500?
No, Immunome, Inc. is not included in the S&P 500 index
Is Immunome, Inc. in the NASDAQ 100?
No, Immunome, Inc. is not included in the NASDAQ 100 index
Is Immunome, Inc. in the Dow Jones?
No, Immunome, Inc. is not included in the Dow Jones index
When was Immunome, Inc.'s last earnings report?
Immunome, Inc.'s most recent earnings report was on May 15, 2025
When does Immunome, Inc. report earnings?
The next expected earnings date for Immunome, Inc. is November 13, 2025